Insmed
INSM
INSM
511 hedge funds and large institutions have $21.1B invested in Insmed in 2025 Q2 according to their latest regulatory filings, with 132 funds opening new positions, 161 increasing their positions, 188 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
511
Holders Change
+76
Holders Change %
+17.47%
% of All Funds
6.85%
Holding in Top 10
33
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+6.45%
% of All Funds
0.44%
New
132
Increased
161
Reduced
188
Closed
52
Calls
$300M
Puts
$356M
Net Calls
-$56.3M
Net Calls Change
+$15.7M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$1.57B |
| 2 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
$1.92B |
| 3 |
D.E. Shaw & Co
New York
|
$344M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
$776M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$513M |
Top Sellers
| 1 |
BlackRock
New York
|
$1.12B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$1.13B |
| 3 |
State Street
Boston,
Massachusetts
|
$431M |
| 4 |
SCM
Suvretta Capital Management
New York
|
$24M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
$114M |
